Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: A study of the children's cancer group (CCG-1884)

Medical and Pediatric Oncology

Volumn 29, Issue 6, 1997, Pages 534-540

  Feig, S A ^a   Harris, R E ^a   Sather, H N ^a  

^a CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Bone marrow transplant; Chemotherapy; Childhood acute lymphoblastic leukemia

Indexed keywords

ASPARAGINASE; BUSULFAN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; HLA ANTIGEN; HYDROCORTISONE; IDARUBICIN; IMMUNOTOXIN; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HLA MATCHING; HUMAN; HUMAN TISSUE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0030929494     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199712)29:6<534::AID-MPO3>3.0.CO;2-L     Document Type: Article

References (40)